Showing 8 of 8 recruiting trials for “melanoma-of-soft-tissue”
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
RecruitingNCT05231655 ↗
Ex VIvo DEtermiNed Cancer Therapy
👨⚕️ Sarah Danson, PhD, FRCP, University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust📍 1 site📅 Started Jul 2021View details ↗
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
👨⚕️ Edmund Bartlett, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Apr 2020View details ↗
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →